Pangaea Oncology SA engages in the provision of molecular diagnostics and research development for cancer treatment. The company was founded by Jose Maestre, Santiago Ramon y Cajal, Rafael Rosell and Javier Rivela in 2006 and is headquartered in Barcelona, Spain.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company